OHSAM Advocacy Issues

OHSAM focuses its advocacy efforts on state legislation and regulation that impact the field of addiction medicine in Ohio. 

Empowering Advocacy: Advocating for Equitable Buprenorphine Regulations in Ohio

Click HERE to watch the zoom meeting.

Empowering Advocacy

MOUD OH Draft letters


Letter Template

Letter of opposition to SB 261

On behalf of the Ohio Society of Addiction Medicine (OHSAM), the medical specialty society representing physicians and clinicians in Ohio who specialize in the treatment of addiction, we write to express our opposition to SB 261, which updates the regulatory framework for the state’s medical cannabis program. 

House Bill 122 was signed and goes into effect  3/23/22.

It gives state medical boards responsibility for establishing a standard of care for telehealth services that is equal to the standard of care for in person services. It forbids boards to require an initial in-person visit for many SUD patients — those MAT patients with a mental health disorder who are in an emergency situation per the health care professional. These can be provided an initial visit remotely via telehealth. Physicians, CNPs and PA’s may provide telehealth services to a patient located outside of this state if permitted by the laws of the state in which the patient is located. It allows health care professionals to charge a health plan issuer, but not a patient, for durable medical equipment used at a patient or client site.

House Bill 5 went into effect as law on 9/30/2021. 
It established new criteria for chemical dependency counselor II. also known as chemical dependency counselor assistants.  The new criteria will go into full force in 3 years.  There is a “grandfather clause”  Until 9/30/24 the criteria won’t apply to those who have provided this level of care since at least December 31, 2008 and have continuously held a valid chemical dependency counselor assistant certificate as well as practiced chemical dependency counseling while under supervision.